KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma, Co-investor Thomas Eldered to Serve as Frontier’s Executive Chairman
KKR, a leading global investment firm, today announced, in partnership with Flerie, the formation of a new global pharma services platform, Frontier Biosolutions ("Frontier"), which will invest in a portfolio